PREDICTING DEATH IN PEDIATRIC-PATIENTS WITH ACUTE RESPIRATORY-FAILURE

Citation
Od. Timmons et al., PREDICTING DEATH IN PEDIATRIC-PATIENTS WITH ACUTE RESPIRATORY-FAILURE, Chest, 108(3), 1995, pp. 789-797
Citations number
24
Categorie Soggetti
Respiratory System
Journal title
ChestACNP
ISSN journal
00123692
Volume
108
Issue
3
Year of publication
1995
Pages
789 - 797
Database
ISI
SICI code
0012-3692(1995)108:3<789:PDIPWA>2.0.ZU;2-7
Abstract
Objective: To estimate mortality risk in pediatric patients with acute hypoxemic respiratory failure (AHRF). Design: Retrospective chart rev iew. Setting: Forty-one pediatric ICUs. Subjects: Four hundred seventy children with AHRF. We defined AHRF as mechanical ventilation with po sitive end-expiratory pressure greater than or equal to 6 cm H2O and f raction of inspired oxygen greater than or equal to 0.5 for 12 or more hours. Measurements: Physiologic and treatment variables were recorde d every 12 h for 14 days. Cases were randomly assigned to score develo pment and score validation subsets. Variables were assessed for their association with mortality in the development subset by logistic regre ssion analysis. The analysis generated a series of logistic equations, which we called the Pediatric Respiratory Failure (PeRF) score, to es timate mortality risk at 12-h intervals over the first ? days of treat ment for AHRF, The predictive ability of the score was assessed in the validation subset by receiver operating characteristic curve area and goodness-of-fit chi(2). Results: Mortality of the collected cases was 43%. The PeRF score included age, operative status, Pediatric Risk of Mortality score, fraction of inspired oxygen, respiratory rate, peak inspiratory pressure, positive end-expiratory pressure, PaO2, and PaCO 2. Area under the receiver operating characteristic curve was 0.769 at entry and increased to greater than 0.8 after 36 h, When the score wa s applied to the validation subset of patients, goodness-of-fit chi(2) showed no significant difference between estimated and actual mortali ty between 0 and 96 h. Conclusions: The PeRF Score accurately estimate d mortality risk in this retrospectively sampled group of high-risk pe diatric patients with AHRF, This score may be useful in studies of new er therapies for pediatric AHRF, though prospective validation is nece ssary before it could be used to make clinical decisions.